Overall, our findings offer the first proof that nVNS decreases key pro-inflammatory cytokines, enhances both BDNF and reduced glutathione levels in PD patients, and that nVNS may even have disease-modifying effects in PD. This evidence concerns the gene BDNF and Parkinson disease.